Seed funding of €2 million has been raised by medtech startup Inflow for its novel science-based app for ADHD patients, according to EU Startups.

Among the investors are Hoxton Ventures and Route 66 Ventures, along with angel investor Quit Genius.

WHY IT MATTERS

With the launch of their innovative app, the London-based founders Levi Epstein and Seb Isaacs want to enable ADHD patients to actively self-manage their disease by means of Cognitive Behavioural Therapy (CBT) strategies.

Attention Deficit Hyperactivity Disorder (ADHD) can bring along manifold symptoms such as a lack of concentration, hyperactivity, anxiety, boredom and depression. Thus, the app provides tools to take on healthier habits through daily exercises, mindfulness techniques, dives into neurological knowledge and helps to change emotional evaluation patterns.

For the app’s development, Inflow’s founders have collaborated with leading clinicians such as ADHD expert Dr George Sachs.

Founded in 2020, the British startup is not even two years old. With the seed funding the team now aims to expand staff, additional tools and services.

THE LARGER TREND

As per scientific findings, ADHD concerns nearly six per cent of children and adolescents worldwide and about 4.6 per cent in Europe.

In the UK a total of three to five per cent of children and around two per cent of adults are diagnosed with ADHD according to the NHS.

Most recently, video game therapy has been tested and explored for ADHD diagnosed children to further develop their emotional regulation skills, as MobiHealthNews reported that video game system maker Mightier raised $17 million last month.​

ON THE RECORD

Seb Isaacs, Co-founder of Inflow, stated: “We knew we could simplify the ADHD care process and reach millions of underserved people living with ADHD. Inflow can offer immediate, affordable, and on-demand support in ways our burdened mental health system simply cannot.”